Lisanti Capital Growth’s Cardiovascular Systems, Inc. CSII Stock Holding History

Lisanti Capital Growth’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-89,460	Closed	-$4.25M	–	143
2019 Q3	$4.25M	Buy	89,460 +52,485	+142%	+$2.47M	1.39%	26
2019 Q2	$1.59M	Buy	+36,975	New	+$1.44M	0.52%	67
2018 Q4	–	Sell	-30,750	Closed	-$1.2M	–	137
2018 Q3	$1.2M	Buy	+30,750	New	+$1.14M	0.42%	88
2017 Q3	–	Sell	-22,870	Closed	-$737K	–	139
2017 Q2	$737K	Buy	+22,870	New	+$697K	0.49%	90
2017 Q1	–	Sell	-51,755	Closed	-$1.25M	–	120
2016 Q4	$1.25M	Buy	51,755 +11,815	+30%	+$290K	1.51%	23
2016 Q3	$948K	Buy	39,940 +14,255	+55%	+$312K	1.2%	37
2016 Q2	$472K	Buy	+25,685	New	+$401K	0.71%	68
2014 Q2	–	Sell	-43,330	Closed	-$1.38M	–	118
2014 Q1	$1.38M	Sell	43,330 -3,755	-8%	-$124K	0.59%	74
2013 Q4	$1.61M	Buy	+47,085	New	+$1.37M	0.68%	68

Other funds holding CSII

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lisanti Capital Growth's CSII Position: Q4 2019 in Review

Lisanti Capital Growth sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2019, closing a stake of 89,460 shares — an estimated $4.25M sold.

Lisanti Capital Growth first reported a position in CSII in Q4 2013 and held it in 9 quarters. The position peaked at $4.25M in Q3 2019. 189 funds tracked by Wall St. Rank hold CSII as of Q4 2019.

Lisanti Capital Growth reported no remaining Cardiovascular Systems, Inc. position as of Q4 2019 after selling out during the quarter.
Lisanti Capital Growth sold 89,460 Cardiovascular Systems, Inc. shares in Q4 2019, an estimated $4.25M.
Lisanti Capital Growth first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 9 quarters.
Lisanti Capital Growth's Cardiovascular Systems, Inc. position peaked at $4.25M in Q3 2019.
189 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2019.

Based on Lisanti Capital Growth's 13F filing for Q4 2019, filed 13 Feb 2020.